FDA Rejects NK1R Antagonist for Gastroparesis
MedPage Today) — The FDA declined to approve tradipitant for adults with symptoms of gastroparesis, or delayed gastric emptying, drugmaker Vanda Pharmaceuticals announced on Thursday. Support for the neurokinin-1 receptor (NK1R) antagonist included…
MedPage Today) — The FDA declined to approve tradipitant for adults with symptoms of gastroparesis, or delayed gastric emptying, drugmaker Vanda Pharmaceuticals announced on Thursday.
Support for the neurokinin-1 receptor (NK1R) antagonist included…
Read More
About Author
